Chris Britten

Head, M&A

Chris leads the M&A activities at Neuraxpharm from sourcing, evaluation through to transaction execution. He has over 25 years’ pharmaceutical industry experience in R&D, corporate development and investment banking. Previously roles include Global Head M&A at Sandoz, Managing Director at the boutique advisor Torreya Partners, Head of Business D...


Roles at Neuraxpharm

  • Head, M&A

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.